Skolnik NS - Search Results

1

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.

Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Blonde L, et al. Among authors: skolnik ns. Adv Ther. 2018 Nov;35(11):1763-1774. doi: 10.1007/s12325-018-0805-y. Epub 2018 Oct 24. Adv Ther. 2018. PMID: 30357570 Free PMC article. Review.

2

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.

Gupta S, Wang H, Skolnik N, Tong L, Liebert RM, Lee LK, Stella P, Cali A, Preblick R. Gupta S, et al. Adv Ther. 2018 Jan;35(1):43-55. doi: 10.1007/s12325-017-0651-3. Epub 2018 Jan 8. Adv Ther. 2018. PMID: 29313285 Free PMC article.

3

From Randomized Controlled Trials to the Real World: Putting Evidence into Context.

Blonde L, Dendy JA, Skolnik N, White JR Jr. Blonde L, et al. J Fam Pract. 2018 Aug;67(8 suppl):S55-S60. J Fam Pract. 2018. PMID: 30137055 No abstract available.

4

Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.

Peng XV, McCrimmon RJ, Shepherd L, Boss A, Lubwama R, Dex T, Skolnik N, Ji L, Avogaro A, Blonde L. Peng XV, et al. Diabetes Ther. 2020 Nov;11(11):2629-2645. doi: 10.1007/s13300-020-00905-y. Epub 2020 Sep 9. Diabetes Ther. 2020. PMID: 32902774 Free PMC article.

5

Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes.

Skolnik N, Del Prato S, Blonde L, Galstyan G, Rosenstock J. Skolnik N, et al. Adv Ther. 2021 Apr;38(4):1715-1731. doi: 10.1007/s12325-020-01614-5. Epub 2021 Feb 23. Adv Ther. 2021. PMID: 33620694 Free PMC article. Review.

6

Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.

Singh D, Han MK, Hawkins NM, Hurst JR, Kocks JWH, Skolnik N, Stolz D, El Khoury J, Gale CP. Singh D, et al. Adv Ther. 2024 Apr 25. doi: 10.1007/s12325-024-02855-4. Online ahead of print. Adv Ther. 2024. PMID: 38664329 Review.

7

Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C.

Skolnik N, Bonnes H, Yeh H, Katz A. Skolnik N, et al. Postgrad Med. 2016 May;128(4):356-63. doi: 10.1080/00325481.2016.1173514. Epub 2016 Apr 18. Postgrad Med. 2016. PMID: 27043045

8

COPD in Primary Care: Key Considerations for Optimized Management: Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease.

Dhand R, Cavanaugh T, Skolnik N. Dhand R, et al. J Fam Pract. 2018 Feb;67(2 Suppl):S19-S27. J Fam Pract. 2018. PMID: 29443333 Review.

9

Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes.

Pablo Frias J, Lorenz M, Roberts M, Dex T, Schmider W, Hurst W, Skolnik N. Pablo Frias J, et al. Curr Med Res Opin. 2019 Apr;35(4):689-695. doi: 10.1080/03007995.2018.1541316. Epub 2018 Dec 6. Curr Med Res Opin. 2019. PMID: 30360647

10

Primary care of asthma: new options for severe eosinophilic asthma.

Skolnik NS, Carnahan SP. Skolnik NS, et al. Curr Med Res Opin. 2019 Jul;35(7):1309-1318. doi: 10.1080/03007995.2019.1595966. Epub 2019 Apr 29. Curr Med Res Opin. 2019. PMID: 30880484 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page